Correlation Between Pyxis Oncology and 180 Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pyxis Oncology and 180 Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pyxis Oncology and 180 Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pyxis Oncology and 180 Life Sciences, you can compare the effects of market volatilities on Pyxis Oncology and 180 Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pyxis Oncology with a short position of 180 Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pyxis Oncology and 180 Life.

Diversification Opportunities for Pyxis Oncology and 180 Life

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Pyxis and 180 is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Pyxis Oncology and 180 Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 180 Life Sciences and Pyxis Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pyxis Oncology are associated (or correlated) with 180 Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 180 Life Sciences has no effect on the direction of Pyxis Oncology i.e., Pyxis Oncology and 180 Life go up and down completely randomly.

Pair Corralation between Pyxis Oncology and 180 Life

Given the investment horizon of 90 days Pyxis Oncology is expected to generate 2.75 times less return on investment than 180 Life. But when comparing it to its historical volatility, Pyxis Oncology is 3.29 times less risky than 180 Life. It trades about 0.02 of its potential returns per unit of risk. 180 Life Sciences is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  2,147  in 180 Life Sciences on August 28, 2024 and sell it today you would lose (1,925) from holding 180 Life Sciences or give up 89.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pyxis Oncology  vs.  180 Life Sciences

 Performance 
       Timeline  
Pyxis Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pyxis Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
180 Life Sciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in 180 Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, 180 Life reported solid returns over the last few months and may actually be approaching a breakup point.

Pyxis Oncology and 180 Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pyxis Oncology and 180 Life

The main advantage of trading using opposite Pyxis Oncology and 180 Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pyxis Oncology position performs unexpectedly, 180 Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 180 Life will offset losses from the drop in 180 Life's long position.
The idea behind Pyxis Oncology and 180 Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance